<?xml version="1.0" encoding="UTF-8"?>
<p id="para60">Efforts to address viral hepatitis in sub-Saharan Africa have been remarkable in recent years. The growing availability of simple point-of-care tests and antiviral therapies at low cost make elimination of viral hepatitis a realistic goal in LMICs, as set out in a 
 <italic>Lancet Gastroenterology &amp; Hepatology</italic> Commission.
 <xref rid="bib5" ref-type="bibr">
  <sup>5</sup>
 </xref> Yet, these encouraging prospects also need to be balanced by the reminder that a large proportion of these viral hepatitis services are not supported by national programmes in most LMICs and, in the midst of further resource limitation, remain incredibly fragile. The COVID-19 pandemic vividly highlights this fragility and the urgent need for innovative and sustainable hepatitis programmes in sub-Saharan Africa. In the face of the COVID-19 pandemic, viral hepatitis services are at great risk of being neglected.
</p>
